Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (4)
  • 2023 (3)
  • 2021 (1)
  • 2020 (3)

Subject

  • Drug Trafficking (523)
  • Guns/Weapons (123)
  • Prescription Drugs (60)
  • Fake Pills (47)
  • Guilty Plea (41)
  • Pharmaceuticals/Pharmacists/Physicians (41)
  • OCDETF/Task Force (40)
  • Take Back Day (38)
  • Money Laundering (37)
  • Outreach/Drug Prevention (32)
  • Overdose (32)
  • Major Law Enforcement Operation (26)
  • Synthetic drugs (19)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Arrests/Convictions - Major (16)
  • Fentanyl Awareness (16)
  • Congressional Affairs (12)
  • Press Conferences (12)
  • Gangs (11)
  • Prevention/Education - DEA websites GSAD, JTT etc (11)
  • One Pill Can Kill (9)
  • Red Ribbon (9)
  • Seizures (Drugs/Property) (8)
  • Dark Web- Internet Trafficking (6)
  • Narcoterrorism (5)
  • Extraditions (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Critical Incident (3)
  • Asset Forfeiture (2)
  • Fentanyl Free America (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Campaigns (1)
  • Counterfeit Pills (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Diversion Division (15)

Drug Name

  • Heroin (2)
  • Methamphetamine (2)
  • Oxycodone (2)
  • Cocaine (1)
  • Fentanyl (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Synthetic Opioids (1)

Field Division

  • Washington, DC (34)
  • New England (33)
  • New York (23)
  • Seattle (22)
  • Chicago (18)
  • Houston (15)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (9)
  • New Orleans (8)
  • San Francisco (7)
  • El Paso (6)
  • Dallas (5)
  • Rocky Mountain (5)
  • Los Angeles (3)
  • Omaha (3)
  • Phoenix (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • Sede (8)
  • St. Louis (7)
Clear All Results
PRESS RELEASE

Owner of Kansas City, Kansas Pharmacy Agrees to Pay $200,000 to Resolve Allegations of Violating the Controlled Substances Act

Septiembre 24, 2025
KANSAS CITY, KAN. – Daniel Reif, Inc., doing business as The Medicine Shoppe, a retail pharmacy in Kansas City, Kansas, entered into a civil settlement agreement with the federal government agreeing to pay $200,000 to resolve allegations the pharmacy violated the civil provisions of the Controlled Substances Act (CSA). The...
Septiembre 24, 2025
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

Mayo 15, 2025
WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
Mayo 15, 2025
PRESS RELEASE

DEA St. Louis Division Safely Disposes of More Than 33,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

Mayo 12, 2025
ST. LOUIS – The Drug Enforcement Administration (DEA) St. Louis Division joined forces with law enforcement agencies across Kansas, Missouri and Southern Illinois to safely dispose of 33,840 pounds of unneeded and expired medications at the 28th National Prescription Drug Take Back Day, April 26. Nationally, more than 620,000 pounds...
Mayo 12, 2025
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

Mayo 08, 2025
WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
Mayo 08, 2025
PRESS RELEASE

Jefferson County Doctor, Staffers Accused of Conspiracy, Health Care Fraud

Julio 08, 2024
ST. LOUIS – A doctor with an office in St. Louis and two employees have been indicted in U.S. District Court and accused of illegally prescribing controlled substances and health care fraud. Dr. David A. Parks, 66, James M. Bilderback, 58, both of Jefferson County, Missouri, and Michelle J. Scheer...
Julio 08, 2024
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

Febrero 26, 2024
WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
Febrero 26, 2024
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

Febrero 07, 2024
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
Febrero 07, 2024
PRESS RELEASE

DEA Encourages Communities to Make Every Day Take Back Day

Enero 24, 2024
WASHINGTON – The U.S. Drug Enforcement Administration has launched a new campaign encouraging the public to make Every Day Take Back Day by utilizing year-round collection sites to dispose of unneeded and unwanted medications. For more than a decade, DEA has worked with state and local law enforcement partners to...
Enero 24, 2024
PRESS RELEASE

Pharmacy Agrees to Pay $250,000 for Improperly Distributing Prescriptions

Septiembre 14, 2023
KANSAS CITY, Kan. - A Kansas City, Kansas, company entered into a civil settlement agreement with the federal government to pay $250,000 to resolve allegations that a retail pharmacy it owns violated the civil provisions of the Controlled Substances Act. Four B. Corporation, doing business as Balls Food Stores, owns...
Septiembre 14, 2023
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

Agosto 07, 2023
WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...
Agosto 07, 2023
Showing 1 - 10 of 15 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster